Anticancer agent 313
Anticancer agent 313 is a MetAP2 inhibitor with an IC50 of 4.11 μM. Anticancer agent 313 activates the transcription factor ATF4 via a non-canonical mTORC1-dependent pathway. Anticancer agent 313 inhibits cancer cell proliferation. Anticancer agent 313 is applicable to the research of breast cancer and pancreatic cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C18H26N2O3Si
- Masse moléculaire:346.50
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
MetAp2 |
Anticancer agent 313 (compound 3) (72 h) inhibits the proliferation of 67nr, 4T1, MDA-MB-231, BxPC3 and MIA PaCa-2 cancer cell lines[1].
Anticancer agent 313 induces ATF4 expression in 67nr, MDA-MB-231 and MIA PaCa-2 cancer cell lines via an mTORC1-dependent non-canonical (eIF2α phosphorylation-independent) mechanism, but has no such effect in 4T1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:67nr, 4T1, MDA-MB-231, BxPC3, MIA PaCa-2 cells
-
Concentration:/
-
Incubation Time:72 h
-
Result:Had IC50 values of 14.4 (67nr), 2.76 (4T1), 17.32 (MDA-MB-231), 16.7 (BxPC3), 9.71 (MIA PaCa-2) μM.
Chemical Information
-
Masse moléculaire 346.50
-
Formule C18H26N2O3Si
-
SMILES
CC(C)[Si](C(C)C)(C(C)C)OC1=CC=C([N+]([O-])=O)C2=CC=CN=C21
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)